MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 180 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 61 | -29.9% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 87 | -8.4% | 0.00% | – |
| Q4 2020 | $2,000 | -99.2% | 95 | -99.4% | 0.00% | -100.0% |
| Q3 2020 | $265,000 | -26.8% | 15,564 | +0.3% | 0.01% | -27.3% |
| Q2 2020 | $362,000 | -43.0% | 15,511 | -76.8% | 0.01% | -26.7% |
| Q3 2019 | $635,000 | -22.7% | 66,951 | -3.4% | 0.02% | -21.1% |
| Q2 2019 | $821,000 | -29.4% | 69,305 | +4.5% | 0.02% | -32.1% |
| Q1 2019 | $1,163,000 | +138.8% | 66,302 | +136.6% | 0.03% | +133.3% |
| Q4 2018 | $487,000 | -21.5% | 28,023 | -20.0% | 0.01% | -20.0% |
| Q4 2016 | $620,000 | -11.9% | 35,034 | -4.0% | 0.02% | -6.2% |
| Q3 2016 | $704,000 | -1.0% | 36,501 | +0.0% | 0.02% | -11.1% |
| Q2 2016 | $711,000 | -1.4% | 36,485 | +6.5% | 0.02% | 0.0% |
| Q1 2016 | $721,000 | +613.9% | 34,244 | +597.4% | 0.02% | +800.0% |
| Q4 2015 | $101,000 | – | 4,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |